https://european-biotechnology.net/wp-content/uploads/2024/11/Alentis-1030x458-1.jpg4581030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-13 08:00:462024-11-13 08:00:46Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/GeldLSP-1030x782-1.jpg7821030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-12 06:30:482024-11-12 06:30:48Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/MSK.jpg533800Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-10 14:20:092024-11-10 14:20:09Harbinger Health to speed up clinical cancer test validation
https://european-biotechnology.net/wp-content/uploads/2024/10/Mayo-Clinic_Gonda_building.jpg480640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-30 11:53:272024-10-30 11:53:27AIgnostics raises US$34m in Series B financing
